Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fc  receptor for the amelioration of experimental ITP

IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1

(2012) Inessa Schwab et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Prevention of T cell activation by interference of internalized intravenous immunoglobulin (IVIg) with MHC II-dependent native antigen presentation

(2011) Éric Aubin et al.   CLINICAL IMMUNOLOGY

Mechanisms of action of intravenous immunoglobulins

(2011) Anne Baerenwaldt et al.   Expert Review of Clinical Immunology

Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway

(2011) Robert M. Anthony et al.   NATURE

Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies

(2010) Jennifer A Tracy et al.   CURRENT OPINION IN NEUROLOGY

What’s new in i.v. immunoglobulin therapy and pemphigus: High-dose i.v. immunoglobulin therapy and its mode of action for treatment of pemphigus

(2010) Yumi AOYAMA   JOURNAL OF DERMATOLOGY

Improved mouse models for the study of treatment modalities for immune-mediated platelet destruction

(2010) Yulia Katsman et al.   TRANSFUSION

Clinical applications of intravenous immunoglobulins (IVIg) - beyond immunodeficiencies and neurology

(2009) H.-P. Hartung et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY